| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0045-2068(02)00008-1 |
| P8608 | Fatcat ID | release_gl6znuo23bbevn2k36sxrwdrnq |
| P698 | PubMed publication ID | 12392704 |
| P2093 | author name string | Christian P Whitman | |
| Krystyna Konopka | |||
| Nejat Düzgüneş | |||
| Susan C Wang | |||
| Elizabeth A Burks | |||
| Nancy R Shine | |||
| P2860 | cites work | Identification of a major co-receptor for primary isolates of HIV-1 | Q22251282 |
| Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase | Q24298754 | ||
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Establishment and characterization of a human acute monocytic leukemia cell line (THP-1) | Q28276146 | ||
| Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro | Q28293679 | ||
| HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 | Q29616094 | ||
| Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease | Q29616432 | ||
| Endogenous mucosal antiviral factors of the oral cavity | Q33547138 | ||
| Endogenous salivary inhibitors of human immunodeficiency virus | Q33684772 | ||
| CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection | Q33782193 | ||
| Catalytic role of the amino-terminal proline in 4-oxalocrotonate tautomerase: affinity labeling and heteronuclear NMR studies | Q34062202 | ||
| Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor | Q34180810 | ||
| The anti-HIV-1 activity associated with saliva | Q34738486 | ||
| Activation of infectious virus from latent human immunodeficiency virus infection of monocytes in vivo | Q35607138 | ||
| Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41. | Q35837553 | ||
| Negative regulation of human immune deficiency virus replication in monocytes. Distinctions between restricted and latent expression in THP-1 cells | Q36351087 | ||
| Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage | Q36380925 | ||
| The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation | Q37648485 | ||
| Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection | Q37925515 | ||
| Interaction of secretory leukocyte protease inhibitor with heparin inhibits proteases involved in asthma | Q38337031 | ||
| Role of macrophages in the pathogenesis of human immunodeficiency virus (HIV) infection | Q38956898 | ||
| Expression of CD4 controls the susceptibility of THP-1 cells to infection by R5 and X4 HIV type 1 isolates | Q39144883 | ||
| In vitro differentiation of monocytoid THP-1 cells affects their permissiveness for HIV strains: a model system for studying the cellular basis of HIV differential tropism | Q39248709 | ||
| Co-receptors for HIV-1 entry | Q39265878 | ||
| Role of cell surface glycosaminoglycans of human T cells in human immunodeficiency virus type-1 (HIV-1) infection | Q39318713 | ||
| Inhibition of human immunodeficiency virus type-1 replication in macrophages and H9 cells by free or liposome-encapsulated L-689,502, an inhibitor of the viral protease | Q41123091 | ||
| Human immunodeficiency virus type-1 (HIV-1) replication is unaffected by human secretory leukocyte protease inhibitor | Q41221414 | ||
| Long-term noncytopathic productive infection of the human monocytic leukemia cell line THP-1 by human immunodeficiency virus type 1 (HIV-1IIIB). | Q41562299 | ||
| Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines | Q41577111 | ||
| Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-I. | Q41697048 | ||
| Secretory leukocyte protease inhibitor (SLPI): oxidation of SLPI does not explain its variable anti-HIV activity | Q41707998 | ||
| Human bronchial leucocyte proteinase inhibitor. Rapid isolation and kinetic analysis with human leucocyte proteinases | Q42848905 | ||
| Human immunodeficiency virus infection of monocytic and T-lymphocytic cells: receptor modulation and differentiation induced by phorbol ester | Q44890078 | ||
| Secretory leukocyte protease inhibitor blocks infectivity of primary monocytes and mononuclear cells with both monocytotropic and lymphocytotropic strains of human immunodeficiency virus type I. | Q45758044 | ||
| HIV1 integrase expressed in Escherichia coli from a synthetic gene | Q48087301 | ||
| Heparin-induced conformational change and activation of mucus proteinase inhibitor. | Q50790111 | ||
| Inhibition of human mast cell chymase by secretory leukocyte proteinase inhibitor: enhancement of the interaction by heparin. | Q52310067 | ||
| In vivo significance of kinetic constants of protein proteinase inhibitors. | Q52684741 | ||
| Refolding of recombinant proteins. | Q54719193 | ||
| Inhibitors of acrosin and granulocyte proteinases from human genital tract secretions | Q67865432 | ||
| Gene synthesis and expression in E. coli for pump, a human matrix metalloproteinase | Q68211179 | ||
| 5 Theoretical and practical aspects of proteinase inhibition kinetics | Q72059257 | ||
| Quantification of granulocyte elastase inhibitors in human mixed saliva and in pure parotid secretion | Q72714638 | ||
| Kinetic, stereochemical, and structural effects of mutations of the active site arginine residues in 4-oxalocrotonate tautomerase | Q73011032 | ||
| Human mucus protease inhibitor in airway fluids is a potential defensive compound against infection with influenza A and Sendai viruses | Q73194504 | ||
| Antileukoprotease: an endogenous protein in the innate mucosal defense against fungi | Q73683984 | ||
| Chemokine receptor regulation and HIV type 1 tropism in monocyte-macrophages | Q74173208 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 249-263 | |
| P577 | publication date | 2002-08-01 | |
| P1433 | published in | Bioorganic Chemistry | Q2904198 |
| P1476 | title | Secretory leukocyte protease inhibitor: inhibition of human immunodeficiency virus-1 infection of monocytic THP-1 cells by a newly cloned protein | |
| P478 | volume | 30 |
| Q33715960 | Anti-inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor |
| Q36095139 | Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection |
| Q35075174 | Comparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluids |
| Q36809170 | Epidemiology, pathogenesis, and management of human immunodeficiency virus infection in patients with periodontal disease |
| Q42575864 | Expression and characterization of recombinant human secretory leukocyte protease inhibitor (SLPI) protein from Pichia pastoris |
| Q36358905 | Genital tract viral load in HIV Type 1-positive women correlates with specific cytokine levels in cervical-vaginal secretions but is not a determinant of infectious virus or anti-HIV activity |
| Q33780434 | Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity |
| Q30398454 | New approaches to making the microenvironment of the female reproductive tract hostile to HIV. |
| Q36741771 | Oral mucosal immunity and HIV/SIV infection |
| Q37116400 | Salivary secretory leukocyte protease inhibitor and oral candidiasis in human immunodeficiency virus type 1-infected persons |
| Q38206217 | Secreted mucosal antimicrobials in the female reproductive tract that are important to consider for HIV prevention |
| Q27680269 | Structure basis 1/2SLPI and porcine pancreas trypsin interaction |
| Q40105217 | The lower genital tract microbiota in relation to cytokine-, SLPI- and endotoxin levels: application of checkerboard DNA-DNA hybridization (CDH). |
| Q21143809 | The phospholipid scramblases 1 and 4 are cellular receptors for the secretory leukocyte protease inhibitor and interact with CD4 at the plasma membrane |
Search more.